These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21747382)

  • 1. Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction.
    Palazzoli F; Bire S; Bigot Y; Bonnin-Rouleux F
    Nat Biotechnol; 2011 Jul; 29(7):593-7. PubMed ID: 21747382
    [No Abstract]   [Full Text] [Related]  

  • 2. US patent office, interfering again.
    Nat Rev Drug Discov; 2002 Oct; 1(10):750. PubMed ID: 12374105
    [No Abstract]   [Full Text] [Related]  

  • 3. First round to Amgen in EPO battle.
    Robertson D
    Nat Biotechnol; 2000 May; 18(5):483. PubMed ID: 10802602
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaborative research presents special problems for patent seekers.
    Thorne LW; Ergenzinger ER; Spruill WM
    Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550
    [No Abstract]   [Full Text] [Related]  

  • 5. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 6. Will pharmacogenomics alter the role of patents in drug development?
    Eisenberg RS
    Pharmacogenomics; 2002 Sep; 3(5):571-4. PubMed ID: 12223043
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2004 Apr; 7(4):388-9. PubMed ID: 15125440
    [No Abstract]   [Full Text] [Related]  

  • 8. Research tool patents: tips for facing a "pay up now or litigate" ultimatum.
    Gogoris A; Ancona P
    Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855
    [No Abstract]   [Full Text] [Related]  

  • 9. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law.
    Blaug S; Shuster M; Su H
    Nat Biotechnol; 2003 Jan; 21(1):97-9. PubMed ID: 12511910
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.
    Rutz B; Yeats S
    EMBO Rep; 2004 Feb; 5(2):119-23. PubMed ID: 14755300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
    Jakas J
    Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220
    [No Abstract]   [Full Text] [Related]  

  • 13. New life for patents.
    Am Fam Physician; 1981 Jul; 24(1):90. PubMed ID: 7258072
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.
    Melethil S
    AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-patent barriers to entry in the pharmaceutical industry.
    Scherer FM
    J Health Econ; 1985 Mar; 4(1):83-7. PubMed ID: 10271148
    [No Abstract]   [Full Text] [Related]  

  • 16. Patents on ice.
    Stix G
    Sci Am; 2004 May; 290(5):48. PubMed ID: 15127661
    [No Abstract]   [Full Text] [Related]  

  • 17. Patenting medical technology.
    Noonan WD
    J Leg Med; 1990 Sep; 11(3):263-319. PubMed ID: 2266323
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of patent term restoration to small, high technology companies.
    Kiley TD
    Health Aff (Millwood); 1982; 1(2):46-52. PubMed ID: 7185722
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL; Kowalski TJ; Jarecki-Black J
    Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent term extension: an expensive and unnecessary giveaway.
    Gore A
    Health Aff (Millwood); 1982; 1(2):25-33. PubMed ID: 10621692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.